2024. Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial. International Journal of Integrated Health Sciences. 12, 1 (Mar. 2024), 55–64. DOI:https://doi.org/10.15850/ijihs.v12.n1.3570.